Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sirnaomics Ltd. ( (HK:2257) ) has issued an update.
Sirnaomics Ltd. has announced its upcoming annual general meeting scheduled for June 20, 2025, in Hong Kong. The meeting will address several key resolutions, including the adoption of financial statements, re-election of directors, and authorization for the board to manage director remuneration and share allotment. These resolutions are crucial for the company’s governance and strategic direction, potentially impacting its market operations and stakeholder interests.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company focused on the development of RNAi therapeutics. The company operates within the pharmaceutical industry, concentrating on innovative therapies for unmet medical needs.
YTD Price Performance: -11.85%
Average Trading Volume: 199,641
Technical Sentiment Signal: Buy
Current Market Cap: HK$320.8M
See more insights into 2257 stock on TipRanks’ Stock Analysis page.